398 related articles for article (PubMed ID: 17015480)
1. TReP-132 is a novel progesterone receptor coactivator required for the inhibition of breast cancer cell growth and enhancement of differentiation by progesterone.
Gizard F; Robillard R; Gross B; Barbier O; Révillion F; Peyrat JP; Torpier G; Hum DW; Staels B
Mol Cell Biol; 2006 Oct; 26(20):7632-44. PubMed ID: 17015480
[TBL] [Abstract][Full Text] [Related]
2. TReP-132 controls cell proliferation by regulating the expression of the cyclin-dependent kinase inhibitors p21WAF1/Cip1 and p27Kip1.
Gizard F; Robillard R; Barbier O; Quatannens B; Faucompré A; Révillion F; Peyrat JP; Staels B; Hum DW
Mol Cell Biol; 2005 Jun; 25(11):4335-48. PubMed ID: 15899840
[TBL] [Abstract][Full Text] [Related]
3. Integrity of the LXXLL motif in Stat6 is required for the inhibition of breast cancer cell growth and enhancement of differentiation in the context of progesterone.
Wei M; He Q; Yang Z; Wang Z; Zhang Q; Liu B; Gu Q; Su L; Yu Y; Zhu Z; Zhang G
BMC Cancer; 2014 Jan; 14():10. PubMed ID: 24401087
[TBL] [Abstract][Full Text] [Related]
4. Progesterone inhibits human breast cancer cell growth through transcriptional upregulation of the cyclin-dependent kinase inhibitor p27Kip1 gene.
Gizard F; Robillard R; Gervois P; Faucompré A; Révillion F; Peyrat JP; Hum WD; Staels B
FEBS Lett; 2005 Oct; 579(25):5535-41. PubMed ID: 16216245
[TBL] [Abstract][Full Text] [Related]
5. The antiprogestin Lonaprisan inhibits breast cancer cell proliferation by inducing p21 expression.
Busia L; Faus H; Hoffmann J; Haendler B
Mol Cell Endocrinol; 2011 Feb; 333(1):37-46. PubMed ID: 21138753
[TBL] [Abstract][Full Text] [Related]
6. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
7. Stat6 cooperates with Sp1 in controlling breast cancer cell proliferation by modulating the expression of p21(Cip1/WAF1) and p27 (Kip1).
Wei M; Liu B; Gu Q; Su L; Yu Y; Zhu Z
Cell Oncol (Dordr); 2013 Feb; 36(1):79-93. PubMed ID: 23184467
[TBL] [Abstract][Full Text] [Related]
8. Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites.
Huang L; Sowa Y; Sakai T; Pardee AB
Oncogene; 2000 Nov; 19(50):5712-9. PubMed ID: 11126357
[TBL] [Abstract][Full Text] [Related]
9. Sam68 up-regulation correlates with, and its down-regulation inhibits, proliferation and tumourigenicity of breast cancer cells.
Song L; Wang L; Li Y; Xiong H; Wu J; Li J; Li M
J Pathol; 2010 Nov; 222(3):227-37. PubMed ID: 20662004
[TBL] [Abstract][Full Text] [Related]
10. Reduction of human metastatic breast cancer cell aggressiveness on introduction of either form a or B of the progesterone receptor and then treatment with progestins.
Sumida T; Itahana Y; Hamakawa H; Desprez PY
Cancer Res; 2004 Nov; 64(21):7886-92. PubMed ID: 15520195
[TBL] [Abstract][Full Text] [Related]
11. Novel role of signal transducer and activator of transcription 3 as a progesterone receptor coactivator in breast cancer.
Proietti CJ; Béguelin W; Flaqué MC; Cayrol F; Rivas MA; Tkach M; Charreau EH; Schillaci R; Elizalde PV
Steroids; 2011 Mar; 76(4):381-92. PubMed ID: 21184768
[TBL] [Abstract][Full Text] [Related]
12. Progestins reinitiate cell cycle progression in antiestrogen-arrested breast cancer cells through the B-isoform of progesterone receptor.
McGowan EM; Russell AJ; Boonyaratanakornkit V; Saunders DN; Lehrbach GM; Sergio CM; Musgrove EA; Edwards DP; Sutherland RL
Cancer Res; 2007 Sep; 67(18):8942-51. PubMed ID: 17875737
[TBL] [Abstract][Full Text] [Related]
13. Taxol-induced growth arrest and apoptosis is associated with the upregulation of the Cdk inhibitor, p21WAF1/CIP1, in human breast cancer cells.
Choi YH; Yoo YH
Oncol Rep; 2012 Dec; 28(6):2163-9. PubMed ID: 23023313
[TBL] [Abstract][Full Text] [Related]
14. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines.
Koga H; Sakisaka S; Harada M; Takagi T; Hanada S; Taniguchi E; Kawaguchi T; Sasatomi K; Kimura R; Hashimoto O; Ueno T; Yano H; Kojiro M; Sata M
Hepatology; 2001 May; 33(5):1087-97. PubMed ID: 11343236
[TBL] [Abstract][Full Text] [Related]
15. Integration of progesterone receptor mediated rapid signaling and nuclear actions in breast cancer cell models: role of mitogen-activated protein kinases and cell cycle regulators.
Faivre E; Skildum A; Pierson-Mullany L; Lange CA
Steroids; 2005; 70(5-7):418-26. PubMed ID: 15862825
[TBL] [Abstract][Full Text] [Related]
16. Activation of protein kinase G Increases the expression of p21CIP1, p27KIP1, and histidine triad protein 1 through Sp1.
Cen B; Deguchi A; Weinstein IB
Cancer Res; 2008 Jul; 68(13):5355-62. PubMed ID: 18593937
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid inhibition of cell cycle progression in MCF-7 human breast cancer cells.
Zhu WY; Jones CS; Kiss A; Matsukuma K; Amin S; De Luca LM
Exp Cell Res; 1997 Aug; 234(2):293-9. PubMed ID: 9260897
[TBL] [Abstract][Full Text] [Related]
18. Progestin drives breast cancer growth by inducing p21(CIP1) expression through the assembly of a transcriptional complex among Stat3, progesterone receptor and ErbB-2.
Diaz Flaqué MC; Vicario R; Proietti CJ; Izzo F; Schillaci R; Elizalde PV
Steroids; 2013 Jun; 78(6):559-67. PubMed ID: 23178160
[TBL] [Abstract][Full Text] [Related]
19. Tamoxifen-induced activation of p21Waf1/Cip1 gene transcription is mediated by Early Growth Response-1 protein through the JNK and p38 MAP kinase/Elk-1 cascades in MDA-MB-361 breast carcinoma cells.
Kim CG; Choi BH; Son SW; Yi SJ; Shin SY; Lee YH
Cell Signal; 2007 Jun; 19(6):1290-300. PubMed ID: 17307334
[TBL] [Abstract][Full Text] [Related]
20. The orphan receptor COUP-TFII regulates G2/M progression of breast cancer cells by modulating the expression/activity of p21(WAF1/CIP1), cyclin D1, and cdk2.
Nakshatri H; Mendonca MS; Bhat-Nakshatri P; Patel NM; Goulet RJ; Cornetta K
Biochem Biophys Res Commun; 2000 Apr; 270(3):1144-53. PubMed ID: 10772965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
